The vast majority of the critically essential secrets in biology are hidden from researchers. The human microbiome is now considered a human organ, yet the word “microbiome” was not in the research lexicon as…
Continue Reading
What You Should Know:– Tempus, the $10B artificial intelligence and precision medicine company, announced their first multi-omics collaboration with Actuate Therapeutics, in which datasets of different omic groups – genomics, transcriptomics, epigenomics, and others…
Continue Reading
Moderna’s ambitions in messenger RNA technology include therapies that do their editing work inside the patient. To that end, the biotech company is starting an R&D collaboration with a division of ElevateBio that brings…
Continue Reading
Heather Bassett, M.D., Chief Medical Officer, XSOLISToday’s relationship between payers and providers is more fraught than ever. With a history of transactional, often adversarial, fee-for-service contract negotiations, it’s no wonder that the healthcare industry…
Continue Reading
Sequencing our 3.2 billion DNA base pairs is becoming increasingly crucial as genomic testing gains widespread acceptance. Advancements in genomics are improving the detection of mutations that can lead to illnesses, with the potential to revolutionize personalized medicine by enabling the development of more effective treatments for genetic disorders. High-performance computing is revolutionizing the field of genomics by accelerating the speed of analysis and processing of large-scale gene sequencing data sets. However, genomics is facing a massive Big Data problem. Scientists are struggling to process a growing volume of data as precision medicine turns to gene sequencing for individual patients….
Continue Reading
